Ubiquitous embryonic expression of the norepinephrine transporter

Developmental Neuroscience

Volumn 25, Issue 1, 2003, Pages 1-13

  Ren, Z G ^a   Porzgen P P ^b   Youn, Y H ^a   Sieber Blum, Maya ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Brain; Cardiovascular system; Floor plate; Kidney; Norepinephrine; Norepinephrine transporter; Notochord; Somite; Spinal cord

Indexed keywords

NEUROTRANSMITTER; NORADRENALIN TRANSPORTER;

ANIMAL CELL; ANIMAL EXPERIMENT; AORTA WALL; ARTICLE; BLOOD CELL; BLOOD VESSEL; BRAIN NUCLEUS; CARDIOVASCULAR SYSTEM; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; EPICARDIUM; FOWL; GERM LAYER; HEART MUSCLE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE; KIDNEY; LIMB BUD; LUNG; MESENCEPHALON; MESENCHYME CELL; MOUSE; MYOTOME; NEURAL CREST; NEUROEPITHELIUM; NONHUMAN; NOTOCHORD; OLFACTORY EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SPINAL CORD VENTRAL HORN; SPINAL GANGLION; SPINAL NERVE; SYMPATHETIC GANGLION; TISSUE DISTRIBUTION; VEIN WALL;

ANIMALS; COTURNIX; EMBRYO; EMBRYO, NONMAMMALIAN; EMBRYONIC AND FETAL DEVELOPMENT; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYMPORTERS;

EID: 0042164873     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071462     Document Type: Article

References (58)

1. Amara SG (1995): Monoamine transporters: Basic biology with clinical implications. Neuroscientist 1:259-267.
2. Axelrod J (1965): The metabolism, storage, and release of catecholamines. Recent Prog Horm Res 21:597-619.
3. Bohn LM, Xu F, Gainetdinov RR, Caron MG (2000): Potentiated opioid analgesia in norepinephrine transporter knock-out mice. J Neurosci 20:9040-9045.
4. Chen JJ, Li Z, Pan H, Murphy DL, Tamir H, Koepsell H, Gershon MD (2001): Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters. J Neurosci 15:6348-6361.
5. Dao HH, Lemay J, de Champlain J, de Bois D, Moreau P (2001): Norepinephrine-induced aortic hyperplasia and extracellular matrix deposition are endothelin-dependent. J Hypertens 19:1965-1973.
6. Deng X-F, Rokosh DG, Simpson PC (2000): Autonomous and growth factor-induced hypertrophy in cultured neonatal mouse cardiac myocytes. Comparison with rat. Circ Res 87:781-788.
7. Eisenhofer G (2001): The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. Pharmacol Ther 91:35-62.
8. Falkenburger BH, Barstow KL, Mintz IM (2001): Dendrodendritic inhibition through reversal of dopamine transport. Science 294:2465-2470.
9. Fiorica-Howells E, Maroteaux L, Gershon, MD (2000): Serotonin and the 5-HT(2B) receptor in the development of enteric neurons. J Neurosci 20:294-305.
10. Freeman JG, Ryan JJ, Shelburne CP, Bailey DP, Bouton, LA, Narasimhachari N, Domen J, Simeon N, Couderc F, Stewart JK (2001): Catecholamines in murine bone marrow derived mast cells. J Neuroimmunol 119:231-238.
11. Galli A, Blakely RD, DeFelice LJ (1996): Norepinephrine transporters have channel modes of conduction. Proc Natl Acad Sci USA 93:8671-8676.
12. 3H]noradrenaline in rat hippocampal slices. Neuroscience 104:761-768.
13. Haller J, Bakos N, Rodriguiz RM, Caron MG, Wetsel WC, Liposits Z (2002): Behavioral responses to social stress in noradrenaline transporter knockout mice: effects on social behavior and depression. Brain Res Bull 58:279-284.
14. Hallmann R, Mayer DN, Berg EL, Broermann R, Butcher EC (1995): Novel mouse endothelial cell surface marker is suppressed during differentiation of the blood brain barrier. Dev Dyn 202:325-332
15. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PPA (1994): International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 446:157-203.
16. Iversen LL (1967): The Uptake and Storage of Noradrenaline in Sympathetic Nerves. New York, Cambridge University Press.
17. Kirby ML, Gilmore SA (1972): A fluorescence study on the ability of the notochord to synthesize and store catecholamines in early chick embryos. Anat Rec 173:469-478.
18. Kobayashi K, Morita S, Sawada H, Mizuguchi T, Yamada K, Nagatsu I, Hata T, Watanabe Y, Fujita K, Nagatsu T (1995): Targeted disruption of the tyrosine hydroxylase locus results in severe catecholamine depletion and perinatal lethality in mice. J Biol Chem 270:27235-27243.
19. Kristufek D, Rudorfer W, Pifl C, Huck S (2002): Organic cation transporter mRNA and function in the rat superior cervical ganglion. J Physiol 15:117-134.
20. 3H-noradrenaline releasing effect of various substrates of uptake 1: Multifactorial induction of outward transport. Naunyn Schmiedebergs Arch Pharmacol 336:602-610.
21. Lauder JM, Tamir H, Sadler TW (1988): Serotonin and morphogenesis. 1. Sites of serotonin uptake and -binding protein immunoreactivity in the midgestation mouse embryo. Development 102:709-720.
22. Lauder JM, Wallace JA, Krebs H, Petrusz P (1980): Serotonin as a timing mechanism in neuroembryogenesis; in Brambilla F, Racagni G, de Wied D (eds): Progress in Psychoendocrinology. Amsterdam, Elsevier.
23. Lo L, Tiveron MC, Anderson DJ (1998): MASH1 activates expression of the paired homeodomain transcription factor Phox2a, and couples pan-neuronal and subtype-specific components of autonomic neuronal identity. Development 125:609-620.
24. Moiseiwitsch, RRD, Lauder JM (1995): Serotonin regulates mouse cranial neural crest migration. Proc Natl Acad Sci USA 92:7182-7186.
25. Moron JA, Brockington A, Wise RA, Rocha BA, Hope BT (2002): Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: Evidence from knock-out mouse lines. J Neurosci 15:389-395.
26. Newgreen DF, Allan IJ, Young HM, Southwell BR (1981): Accumulation of exogenous catecholamines in the neural tube and non-neuronal tissues of the early fowl embryo. Wilhelm Rouxs Arch 190:320-330.
27. Nisoli E, Regianini L, Bulbarelli A, Briscinin L, Breacale R, Carruba MO (2001): Protective effects of noradrenaline against tumor necrosis factor-alpha-induced apoptosis in cultured rat brown adipocytes: Role of nitric oxide-induced heat shock protein 70 expression. Int J Obes Relat Metab Disord 25:1421-1430.
28. Pacholczyk T, Blakely RD, Amara SG (1991): Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350:320-353.
29. Panabieres F, Piechaczyk M, Rainer B, Dani C, Fort P, Riaad S,Marti L, Imbach JL, Jeanteur P, Blanchard, J-MM (1984): Complete nucleotide sequence of the messenger RNA coding for chicken muscle glyceraldehyde-3-phosphate dehydrogenase. Biochem Biophys Res Commun 118:767-773.
30. Pardanaud L, Altmann C, Kitos P, Dieterlen-Lievre F, Buck CA (1987): Vasculogenesis in the early quail blastodisc as studied with amonoclonal antibody recognizing endothelial cells. Development 100:339-349.
31. Paton DM (1973): Mechanisms of efflux of nor-adrenaline from adrenergic nerves in rabbitatria. Br J Pharmacol 49:6114-627.
32. Pifl C, Singer EA (1999): Ion dependence of carrier-mediated release in dopamine or norepinephrine transporter-transfected cells questions the hypothesis of facilitated exchange diffusion. Mol Pharmacol 56:1047-1054.
33. Pifl, C, Zezuela J, Spittler A, Kattinger A, Reither H, Caron MG, Hornykiewicz O (2001): Antiproliferative action of dopamine and norepinephrine in neuroblastoma cells expressing the human dopamine transporter. FASEB J 15:1607-1609.
34. Pönicke K, Schlüter K-D, Heinroth-Hoffman I, Seyfarth T, Goldberg M, Osten B, Piper HM, Brodde O-E (2001): Noradrenaline-induced increase in protein synthesis in adult rat cardiomyocytes: Involvement of only α1A-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 264:444-453.
35. Portbury AL, Chikaraishi DM (2001): The role of norepinephrine and 3 adrenergic receptors in fetal development. Soc Neurosci Abstr 27:838.2.
36. Povlock SL, Amara SG (1997): The structure and function of norepinephrine, dopamine and serotonin transporters; in Reith MEA (ed): Neurotransmitter Transporters, Structure, Function and Regulation. Totawa, Humane Press, pp 1-28.
37. Reissmann E, Ernsberger U, Francis-West PH, Rueger D, Brickell PM, Rohrer H (1996): Involvement of bone morphogenetic protein-7 in the differentiation of the adrenergic phenotype in developing sympathetic neurons. Development 122:2079-2088.
38. Ren ZG, Pörzgen PP, Zhang JM, Chen XR, Amara SG, Blakely RD, Sieber-Blum M (2001): Autocrine regulation of norepinephrine transporter expression. Mol Cell Neurosci 17:539-550.
39. Rios M, Habecker B, Sasaoka T, Eisenhofer G, Tian H, Landis S, Chikaraishi D, Roffler-Tarnoff S (1999): Catecholamine synthesis is mediated by tyrosinase in the absence of tyrosine hydroxylase. J Neurosci 19:3519-3526.
40. Rothman TP, Gershon MD, Holtzer H (1978): The relationship of cell division to the acquisition of adrenergic characteristics by developing sympathetic ganglion cell precursors. Dev Biol 65:322-341.
41. Schomig A, Fischer S, Kurz T, Richardt G, Schomig E (1987): Nonexocytotic release of endogenous noradrenaline in the ischemic and anoxic rat heart: Mechanism and metabolic requirements. Circ Res 60:194-205.
42. Schroeter S, Apparsundaram S, Wiley RG, Miner LAH, Sesack SR, Blakely RD (2000): Immunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter. J Comp Neurol 420:211-232.
43. Shuey DL, Sadler TW, Lauder JM (1992): Serotonin as a regulator of craniofacial morphogenesis: Site-specific malformations following exposureto serotonin uptake inhibitors. Teratology 46:367-378.
44. Sieber-Blum M (1989): Inhibition of the adrenergic phenotype in cultured neural crest cells by nor-epinephrine uptake inhibitors. Dev Biol 136:372-380.
45. Sieber-Blum M, Ren ZG (2000): Norepinephrine transporter expression and function in noradrenergic cell differentiation. Mol Cell Biochem 212:61-70.
46. Singh K, Xiao L, Remondino A, Sawyer DB, Colucci WS (2001): Adrenergic regulation of cardiac myocyte apoptosis. J Cell Physiol 189:257-265.
47. Snyder SH (1970): Putative neurotransmitters in the brain: Selective neuronal uptake, subcellular localization, and interactions with centrally acting drugs. Biol Psychiatry 2:367-389.
48. Strudel G, Recasens M, Mandel P (1977): Identification de catecholamines et de serotonine dans les chordes d'embryons de poulet. CR Acad Sci Paris 284:967-969.
49. Tessarollo L, Parada LF (1995): In situ hybridization. Methods Enzymol 254:419-430.
50. Troadec JD, Marien M, Darios F, Hartmann A, Ruberg M, Colpaert F, Michel PP (2001): Noradrenaline provides long-term protection to dopaminergic neurons by reducing oxidative stress. J Neurochem 79:200-210.
51. 2-adrenoceptors in the medaka, Oryzias latipes. Pigment Cell Res 14:356-361.
52. Varley JE, Maxwell GD (1996): BMP-2 and BMP-4, but not BMP-6 increase the number of adrenergic cells which develop in quail trunk neural crest cultures. Exp Neurol 140:84-94.
53. Varley JE, Wehby RG, Rueger DC, Maxwell GD (1995): Number of adrenergic and islet-1 immunoreactive cells increased in avian trunk neural crest cultures in the presence of human recombinant osteogenic protein-1. Dev Dyn 203:434-437.
54. Wallace JA (1982): Monoamines in the early chick embryo: Demonstration of serotonin synthesis and the regional distribution of serotonin-concentrating cells during morphogenesis. Am J Anat 165:261-276.
55. Wang RX, Limbird LE (1997): Distribution of mRNA encoding three alpha 2-adrenergic receptor subtypes in the developing mouse embryo suggests a role for the alpha 2A subtype in apoptosis. Mol Pharmacol 52:1071-1080.
56. Xu F, Gainetdinov RR, Wetsel WC, Jones SR, Bohn LM, Miller GW, Wang YM, Caron MG (2000): Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat Neurosci 3:465-471.
57. Zhang JM, Dix J, Langtimm-Sedlak CJ, Trusk T, Schroeder B, Hoffmann R, Strosberg AD, Winslow JW, Sieber-Blum M (1997): Neurotrophin-3- and norepinephrine-mediated adrenergic differentiation and the inhibitory action of desipramine and cocaine. J Neurobiol 32:262-280.
58. Zhang J-M, Sieber-Blum M (1992): Characterization of the norepinephrine uptake system and the role of norepinephrine in the expression of the adrenergic phenotype by quail neural crest cells in clonal culture. Brain Res 570:251-258.